Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal population designs for PK models with serial sampling.

Robert Gagnon1, Sergei Leonov

  • 1GlaxoSmithKline, Collegeville, Pennsylvania 19426-0989, USA.

Journal of Biopharmaceutical Statistics
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Continuous Positive Airway Pressure on Glucose Profiles in Gestational Diabetes: A Pilot Randomized Controlled Trial.

American journal of respiratory and critical care medicine·2024
Same author

Positive Airway Pressure Treatment of Obstructive Sleep Apnea-Hypopnea in Hypertensive Disorders of Pregnancy: A Pilot Randomized Proof-of-Concept Clinical Trial.

Annals of the American Thoracic Society·2024
Same author

Perinatal morbidity among women with a previous caesarean delivery (PRISMA trial): a cluster-randomised trial.

Lancet (London, England)·2023
Same author

Type of infertility and prevalence of congenital malformations.

Paediatric and perinatal epidemiology·2023
Same author

Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade.

Cancer research communications·2023
Same author

Directive clinique n<sup>o</sup> 439 : Diagnostic et prise en charge du vasa prævia.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2023
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Optimizing clinical study sampling schemes can reduce sample sizes without losing precision. This approach enhances parameter estimation accuracy and considers experimental costs for efficiency.

Area of Science:

  • Pharmaceutical research
  • Pharmacokinetics and pharmacodynamics (PK/PD) modeling
  • Statistical analysis in clinical trials

Background:

  • Repeated measurements are common in pharmaceutical studies for parameter estimation.
  • Parameter estimate precision, traditionally measured by variance-covariance matrix, reflects experimental data quality.
  • Clinical PK studies often involve serial blood sampling, leading to complex nonlinear mixed-effects models.

Purpose of the Study:

  • To optimize the precision of parameter estimates in clinical PK studies.
  • To determine the optimal number and allocation of sampling times.
  • To incorporate experimental costs into the comparison of sampling schemes.

Main Methods:

  • Focusing on clinical PK studies with multiple blood samples per patient.

Related Experiment Videos

  • Modeling these studies using nonlinear mixed-effects regression with multiple responses.
  • Treating patient sampling schemes as multidimensional points in admissible sampling sequences.
  • Developing an optimization approach to find the best sampling times.

    • Main Results:

    • Demonstrated optimization of parameter estimate precision through sampling time allocation.
    • Showed that a reduced number of samples can be used without significant loss of precision.
    • Integrated experimental costs into the evaluation of sampling schemes.

    Conclusions:

    • Optimized sampling schemes can maintain or improve parameter estimation precision.
    • Reduced sample sizes are feasible, leading to potential cost savings.
    • The developed approach offers a more meaningful comparison of sampling strategies in pharmaceutical research.